plasma; CRC tissues; normal adjacent tissue
HCT116; HT29; SW480; SW620; NCM460
-
not specified
RT-qPCR; Clinical Sample Validation; ROC Analysis; Survival Analysis; Cohort Study
Plasma hsa_circ_0001821 is increased in CRC, HCC and lung cancer and shows diagnostic value by ROC; in CRC, high plasma hsa_circ_0001821 correlates with advanced stage and poorer prognosis and is an independent predictor by Cox regression.
The study reports that plasma hsa_circ_0001821 is up-regulated in CRC (also in HCC and lung cancer) and can serve as a noninvasive diagnostic biomarker with ROC performance. In CRC, higher plasma levels are associated with advanced stage and poorer overall survival, and hsa_circ_0001821 is an independent prognostic predictor in Cox regression.
0.4992
Plasma circular RNA hsa_circ_0001821 acts as a novel diagnostic biomarker for malignant tumors.
combined biological and clinical study